Bayer Pharma AG

Essence of this Article

Thrombosis, the formation of a blood clot within the circulatory system, is a leading cause of death and disability. The risk of thrombosis after major surgery is high, and approximately one out of every two patients undergoing major orthopaedic surgery without thromboprophylaxis will develop deep vein thrombosis (DVT). Other illnesses are also associated with a high risk of thrombosis, and up to 15% of patients hospitalized for an acute medical illness develop venous thromboembolic disease. In Europe, it is estimated that there are more deaths each year as a result of venous thromboembolism (VTE) than caused by breast cancer, prostate cancer, AIDS and transport accidents combined.

The Need For Prevention

The need for venous thromboembolism prevention

Thrombosis, the formation of a blood clot within the circulatory system, is a leading cause of death and disability:

  • Approximately one out of every two patients undergoing major orthopaedic surgery without thromboprophylaxis will develop deep vein thrombosis (DVT)54
  • Up to 15% of patients hospitalized for an acute medical illness develop venous thromboembolic disease55
  • In Europe, it is estimated that there are more deaths each year as a result of VTE than caused by breast cancer, prostate cancer, AIDS and transport accidents combined56

VTE is a major cause of death. European data.56 AIDS, acquired immunodeficiency syndrome; VTE, venous thromboembolism.


Where to next?